Digitoxin

This classification denotes an enzyme inhibitor and cardiotonic agent with the molecular formula C41H64O13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) E90NZP2L9U, chemically known as purodigin, crystalline but more generally known as digitoxin, which bears US NIH Compound Identifier 3061. European Medicines Agency schedules Digitoxin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07133MIG. The term DIGITOXIN is an International Non-Proprietary Name. World Health Organization schedules digitoxin in its Anatomical Therapeutic Chemical (ATC) Classification. DIGITOXIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule digitoxin under HS 29389010 and SITC 54161. As of Q4 2014, DIGITOXIN remains US FDA's Preferred Term for this commodity. Digitoxin bears US NLM identifiers UMLS ID C0012258 and NCI Concept Code C2634. SMILES: OC12C3C(C4(C(CC3)CC(OC3OC(C(OC5OC(C(OC6OC(C(O)C(O)C6)C)C(O)C5)C)C(O)C3)C)CC4)C)CCC1(C(CC2)C1=CC(=O)OC1)C.